These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28466777)

  • 1. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
    Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
    Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
    Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
    Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.
    Yao H; Yang Z; Liu Z; Miao X; Yang L; Li D; Zou Q; Yuan Y
    Cancer Biomark; 2016; 17(4):397-404. PubMed ID: 27689616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.
    Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X
    Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDHB and FABP4 are Associated With Progression and Poor Prognosis of Pancreatic Ductal Adenocarcinomas.
    Luo Y; Yang Z; Li D; Liu Z; Yang L; Zou Q; Yuan Y
    Appl Immunohistochem Mol Morphol; 2017; 25(5):351-357. PubMed ID: 26657874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
    Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2016; 17(4):437-444. PubMed ID: 27802195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
    Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
    World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas.
    Liang S; Yang Z; Li D; Miao X; Yang L; Zou Q; Yuan Y
    Dis Markers; 2015; 2015():379568. PubMed ID: 26294807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
    Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
    Huang J; Fan X; Wang X; Lu Y; Zhu H; Wang W; Zhang S; Wang Z
    Sci Rep; 2015 Aug; 5():12991. PubMed ID: 26259918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AQP1 and AQP3 Expression are Associated With Severe Symptoms and Poor-prognosis of the Pancreatic Ductal Adenocarcinoma.
    Zou W; Yang Z; Li D; Liu Z; Zou Q; Yuan Y
    Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):40-47. PubMed ID: 30531392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis.
    Huang Y; Zheng J; Tan T; Song L; Huang S; Zhang Y; Lin L; Liu J; Zheng P; Chen X; Chen X; Ouyang X
    Int J Biol Markers; 2018 May; 33(2):189-194. PubMed ID: 29076521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
    Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
    Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
    Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma.
    Yin Y; Zhu X; Huang S; Zheng J; Zhang M; Kong W; Chen Q; Zhang Y; Chen X; Lin K; Ouyang X
    Tumour Biol; 2017 Jun; 39(6):1010428317699131. PubMed ID: 28618924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of FZD1 and CAIX are Associated with Invasion, Metastasis, and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma.
    Yang L; Yang Z; Li D; Liu Z; Zou Q; Yuan Y; Xu H
    Pathol Oncol Res; 2018 Oct; 24(4):899-906. PubMed ID: 28921449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Park H; Lee Y; Lee H; Kim JW; Hwang JH; Kim J; Yoon YS; Han HS; Kim H
    Tumour Biol; 2017 Oct; 39(10):1010428317718403. PubMed ID: 29025374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jagged1 and DLL4 expressions in benign and malignant pancreatic lesions and their clinicopathological significance.
    Huang SF; Yang ZL; Li DQ; Liu ZY; Wang CW; Miao XY; Zou Q; Yuan Y
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):640-646. PubMed ID: 27919854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.